Chief Financial Officer and Head, Corporate Development at Unity Biotechnology, Inc.
Ms. Sullivan most recently served as Chief Financial Officer for Compass Therapeutics, LLC. Prior to Compass, Ms. Sullivan served as the Senior Vice President of Finance for Biogen, Inc., where she spearheaded Biogen’s Financial Planning & Analysis, Corporate Tax, and Corporate Finance groups, which includes ownership of long-range planning, capital allocation projects and the financial aspects of Mergers & Acquisitions/Business Development. Prior to that, Ms. Sullivan was the Vice President of Tax for Biogen, Vice President Tax for EMD Serono and the Vice President of Tax North America at Merck KgaA. Ms. Sullivan serves also on the Boards of resTORbio and Solid Biosciences.
Source: BiomX Inc. on 06/13/2023
By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Lynne Marie Sullivan. More specifically, you'll be able to:
Access over 2,000,000 executive and board member profiles.
Example: Lynne Marie Sullivan